Schroder Investment Management Group
HITK

Schroder Investment Management Group’s HI-TECH PHARMACAL INC HITK Stock Holding History

Schroder Investment Management Group’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-218,000
Closed -$7.24M – 1701
2013
Q2 		$7.24M Buy
+218,000
New +$7.26M 0.02% 671

Other funds holding HITK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Schroder Investment Management Group's HITK Position: Q3 2013 in Review

Schroder Investment Management Group sold out of HI-TECH PHARMACAL INC (HITK) in Q3 2013, closing a stake of 218,000 shares — an estimated $7.24M sold.

Schroder Investment Management Group first reported a position in HITK in Q2 2013 and held it in 1 quarter. The position peaked at $7.24M in Q2 2013. 105 funds tracked by Wall St. Rank hold HITK as of Q3 2013.

  • Schroder Investment Management Group reported no remaining HI-TECH PHARMACAL INC position as of Q3 2013 after selling out during the quarter.
  • Schroder Investment Management Group sold 218,000 HI-TECH PHARMACAL INC shares in Q3 2013, an estimated $7.24M.
  • Schroder Investment Management Group first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 1 quarter.
  • Schroder Investment Management Group's HI-TECH PHARMACAL INC position peaked at $7.24M in Q2 2013.
  • 105 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q3 2013.

Based on Schroder Investment Management Group's 13F filing for Q3 2013, filed 8 Nov 2013.